January 2022 - The Epidemiology Monitor by The Epidemiology Monitor

Experts Call For A National Strategy To Manage Control Of An Endemic COVID-19 It Requires Agreeing On An “Acceptable” Number Of Deaths The SARS-CoV-2 pandemic has yet to end, but several observers have begun to identify lessons learned or to call for a national strategy for dealing with the anticipated new realities of living with COVID-19 under endemic rather than pandemic conditions. Other experts have called this effort premature in light of the remaining unknowns, and even those calling for the new strategy acknowledge the uncertainty and call for humility in making predictions. More than 2,000 COVID deaths in the US are still occurring each day.

What Endemicity Requires Writing in a series of commentaries in JAMA and in a special JAMA interview, experts who helped create President Biden’s COVID strategy a year ago are now seeking to focus attention not so much on what remains to be accomplished to make COVID endemic, but instead on what endemic conditions will require if we are to maintain a desired degree of control over endemic COVID. - Strategy con't on page 2

Communication During The COVID-19 Pandemic Being Seen As Flawed And Ineffective “The most consistently botched part of the US pandemic response” is how one commentator evaluated the public health efforts at communication during the COVID-19 pandemic. Other commentators have been even harsher in their criticisms by accusing public officials of making bad decisions and even lying or being deceitful about what they were saying.

November 2021

Some Failures Recognized Concern about communication has existed for some time. The National Academies undertook a review of communications during the COVID health crisis last year and made several recommendations last month. And the - Communication cont'd on page 4

•

Volume Forty Three •

Number One

In This Issue -3Hopkins Report On Tons of Bad Info -5Notes On People -7Event Calendar -8Marketplace This Month

-Strategy cont'd from page 1 The Epidemiology Monitor ISSN (0744-0898) is published monthly by Roger Bernier, Ph.D., MPH at 7033 Hanford Dr,, Aiken, SC, 29803, USA. Editorial Contributors Roger Bernier, PhD, MPH Editor and Publisher

Operations Linda Bernier, PhD, MS Operations Manager

Advertising Sales Linda Bernier, PhD, MS Director of Advertising 770.533.3436 linda@epimonitor.net Advertising Rates All ads listed below also include a banner ad on our website and in our EpiGram emails. Full Page $1,195 7.5”w x 10” h Half Page $895 7.5”w x 4.75” h Website Ad $495 / mo. Includes a banner ad in our EpiGram emails Multi-month discounts available upon request.

All Respiratory Viruses

Rebuilding Public Health

In a viewpoint article entitled “A New National Strategy for the ‘New Normal’ of Life With COVID”, Ezekiel Emmanuel and colleagues argue that the nation needs to set a goal which does not include “zero COVID” and instead includes an acceptable level of national risk caused by all the endemic respiratory viruses such as Influenza, Respiratory Syncytial Virus, SARSCoV-2, and others. This lumping together of respiratory viruses is justified on the grounds that control measures, such as masking or ventilation, are similar for this group of viruses.

Based on their predictions, Ezekiel and colleagues envision a need to rebuild public health in four major areas. These are: 1. A public health data system that can provide comprehensive, real time, information that can reliably be used to assess a situation and can be trusted to take action with. 2. A public health worforce able to meet ongoing as well as surges in demand. It should include community public health workers and an expanded school nurse system. 3. Measures should be taken to make it easier for services to be directed to hard hit areas. 4. There is a need to rebuild trust in public health institutions and to increase public belief that collective action is needed for success in public health.

How Many Deaths We Can Live With To judge the acceptable level of endemic risk, the authors posit that the level which existed prior to COVID should be used as a benchmark since this level in the past did not trigger the declaration of a national emergency with its attendant disruptive control measures. Using this framework, the acceptable risk threshold the authors calculate is approximately 35,000 hospitalizations and 3,000 deaths in a week. The authors acknowledge tolerance for risk from these events varies among communities and no appropriate thresholds have yet been agreed to. Also, they make clear that the US is currently far from dropping below this possibly acceptable risk threshold. At present, over 14,000 deaths occur each week. In fact, the latest CDC data on excess deaths from COVID reveals that the number of deaths from all causes remain above the expected calculated from six previous years of death information prior to 2020.

The lives lost and the losses in gross domestic product because of the pandemic provide more than adequate justification for the large investments needed to rebuild public health, according to Ezekiel and colleagues. Other Biden advisers led by David Michaels and Luciana Borio writing in separate commentaries in JAMA have called for additional public health and medical initiatives in testing, surveillance, mitigation strategies, vaccines, and therapeutics. To read these JAMA commentaries and interview, visit: https://bit.ly/3rT3x66 https://bit.ly/3rOXaRw https://bit.ly/3KMmGiI https://bit.ly/3rRPhuA ■

Hopkins Center Makes Visible The Harms And Costs Of Bad Information Related To COVID-19 The Hopkins Center for Health Security is studying the burden of negative outcomes associated with misinformation and disinformation and calling for a strategy to combat both of these theoretically preventable effects on human beliefs and behaviors.

total harm every day since May 2021 according to the Center's estimates. Thus, assuming beliefs are not fully solidified, millions of dollars could be saved every month while the pandemic continues if effective countermeasures could be applied.

Consequences

National Strategy

According to a recent Center report, “contradictory messaging (misinformation) and active subversion (disinformation) have reduced trust in public health responders, increased belief in false medical cures, and politicized public health measures.” The combined effects can “lead to more infections, deaths, disruptions, and disorganization of the effort.” There are no easy solutions according to the Center, but it has called for a national strategy to address the issues. It is also trying to make sure the costs do not remain invisible to public health and the political leadership.

As part of a national strategy, the Center has called for approximately a dozen countermeasures. Some of these are:

Non-Vaccination In studying one facet of the problem, namely the “misinformation or disinformation-informed decision” to not get a COVID-19 vaccine, the Center estimates that 2-12 million persons are unvaccinated because of exposure to these types of incorrect information. The total of voluntary COVID-19 nonvaccination has caused at least $1 billion of harm each day in the United States since vaccines became widely available, according to the Center. Assuming that 5-30% of this harm comes from misinformation and disinformation, they have caused between $50 and $300 million worth of

“It is also trying to make sure the costs do not remain invisible..."

--Encourage active, transparent, nonpartisan intervention from social media and news media companies to identify and remove, control the spread of, and curtail generators of false information. --Safeguard and promote health and digital literacy through multiple sources including schools, community organizations, social media, news media, and others to help information consumers choose responsible sources of information and increase their awareness of disinformation tactics and approaches. --Improve resources for public verification of questionable content through the development of a robust fact-checking infrastructure with support, training, and guiding principles for fact-checking organizations. The Center’s reports can be accessed at: https://bit.ly/3r1gxHS https://bit.ly/3rTgj4C ■

" The total of voluntary COVID19 nonvaccination has caused at least $1 billion of harm each day in the United States..."

-Communication cont'd from page 1

“...the 'pandemic threw curveballs that she should have anticipated'...”

“The public health sector must increasingly shift toward the practice of 'radical transparency'..."

CDC Director told the Wall Street Journal that the “pandemic threw curveballs that she should have anticipated” and that she should have made it clearer to the public that guidance was subject to change as we learned more about SARS-CoV-2. Serious Communication Challenges Whatever the final verdict rendered about the public communication aspects of the US pandemic response, many of the critics and reviewers have made clear that the challenges were daunting. The list of some of these challenges is impressive and includes 1) the speed at which the pandemic was evolving, 2) the difficulty of coordination during a transition in presidential administrations, 3) the difficulties of coordination between independent agencies, 4) the varying populations affected by the pandemic, 5) the complexities of the science to be communicated to an unprepared public, 6) the overly paternalistic mindset of some in the leadership, 7) the lack of forthrightness about why recommendations were being made, 8) the polarization among the American people to begin with, 9) the overemphasis on “following the science” when not all decisions could or should be made on that basis alone, 10) the numerous sources of information made possible by social media, and 11) relatedly, the prevalence of competing misinformation and disinformation. Insights and Recommendations

These challenges were manifested on several fronts during the pandemic such as communication failures around masks and masking, booster doses, isolation measures, and about the use

of testing. Some of the recommendations derived from the work of the National Academies group are:  Messaging needs to be relatable, plain, and honest. The public health sector must increasingly shift toward the practice of “radical transparency” by telling people what is known, what is not known, and why. 

Public health experts should focus on listening and nonjudgmentally providing information to people responding to genuine questions and needs, focusing on education and knowledge before behavior change.



Communications should be adapted at the individual and community levels and take into account how centrally developed communications methods can be rooted in patriarchy, colonial oppression, and structural racism. Without this understanding, communications cannot be appropriately adapted to local contexts, and therefore may be rejected by many communities. The creation of revitalized convening and coordinating bodies which are already performing these functions



The Academies group also shared their perspective on countering misinformation and disinformation. (see related story in this issue). To read the National Academies report, visit : https://bit.ly/3fUDBBC ■

Notes on People Do you have news about yourself, a colleague, or a student? Please help The Epidemiology Monitor keep the community informed by sending relevant news to us at this address for inclusion in our next issue. people@epimonitor.net

Died: Zena Stein, age 99, emerita professor of Columbia Mailman School of Public Health. As reported by Columbia, Stein advanced public health science while integrating social justice into every aspect of her work. She and her late husband Mervyn Susser, chair of epidemiology at Columbia Mailman School from 1966 to 1978, were seminal figures in the establishment of the discipline of epidemiology, said the school. According to a remembrance by her three children, including her son Ezra, a professor of epidemiology at Columbia, “She was a brilliant and extraordinary woman whose warmth, caring and insights illuminated the lives she touched at home and thousands across the world.” A full biography is available at: https://bit.ly/3G0Q1T9

Appointed: Una Grewal, as Director of the Division of Population Health Research (DiPHR) at the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) at the National Institutes of Health. Dr Grewal had been serving as the acting director since February 2020 and previously served as Deputy Director of DiPHR from 2013 to 2020.

Died: Stanley Music, age 82, in Tbilisi Georgia following onset of severe COVID symptoms. Dr Music was a highly regarded epidemiologist who served in a variety of governmental roles at the state, federal, and international levels. According to a bereavement notice from the Centers for Disease Control and Prevention, Dr Music was most notably known for his work with the World Health Organization on smallpox eradication from 1973-1975 in Bangladesh. To read a full obituary describing his varied career, visit: https://bit.ly/3u0cwVO

Appointed: Tom Inglesby, as the White House Covid testing director, according to White House spokesperson Jen Psaki. Inglesby is currently Director of the Johns Hopkins Center for Health Security in Baltimore, and has held multiple positions related to infectious diseases and public health preparedness. US testing capacity has grown from 50 million in September 2021to 300 million now. Inglesby told Bloomberg “We’re going to keep moving at this speed and faster.” The federal government will release a plan for shipping 500 million tests to US households.

Retiring: Kris Ehresmann, on February 2, 2022, as Infectious Disease Director from the Minnesota Department of Health, according to the Associated Press. Dr Ehresmann has served for more than three decades at the Health Department. She is a leading national expert on influenza and played leading roles in controlling the measles outbreak in 2017 and the swine flu pandemic in 2009.

Diagnosed: Mary-Louise McLaws, professor of epidemiology at the University of New South Wales and advisor to the World Health Organization, with a brain tumor according to her Twitter account. She told followers, “After a severe headache Thursday, I was diagnosed with a brain tumor. I will now be on a month’s sick leave from UNSW and WHO.” News reports indicated that Dr McLaws had become a recognizable public figure in Australia for her guidance and commentary on the COVID-19 pandemic.

Join us on our Facebook page at: https://bit.ly/2U29gUA

8 Near Term Epidemiology Event Calendar Every December The Epidemiology Monitor dedicates that issue to a calendar of events for the upcoming year. However that often means we don't have full information for events later in the upcoming year. Thus an online copy exists on our website that is updated regularly. To view the full year please go to: http://www.epimonitor.net/Events The events that we are aware of for the next two months follow below.

February 2022 February 6-10 https://bit.ly/3IT9d7O Conference / 33rd International Congress on Occupational Health / International Commission on Occupational Health / VIRTUAL February 14-18 https://bit.ly/2RPzuJl Short Course / Pharmaco-epidemiology and Drug Safety / Erasmus MC / Rotterdam, The Netherlands February 28 - March 4 http://bit.ly/2YqNE82 Short Course / Environmental Health Risk (formerly Analyzing Risk) / Harvard University / Boston, MA February 28 - March 4 https://bit.ly/3GK6I61 Short Course / Genetic Epidemiology / University of Bristol / VIRTUAL

March 2022 March 1-4 http://bit.ly/2P1uouz Conference / Epi Lifestyles 2022 Scientific Sessions / American Heart Association / Chicago, IL - Hybrid March 6-9 https://bit.ly/3DPsovK Conference / 11th International Conference on Emerging Infectious Diseases / CDC / Atlanta, GA March 7-11 http://bit.ly/33XqJSJ Short Course / Intensive Course in Applied Epidemiology / University of Aberdeen / Aberdeen, Scotland March 10-11 http://bit.ly/353kNZY Conference / 93rd Annual Meeting - American Epidemiological Society / AES / Atlanta, GA March 13-15 http://bit.ly/34XZw3L Conference / 46th Annual Conference - American Society of Preventive Oncology / ASPO / Tucson, AZ March 14-18 https://bit.ly/320OvlT Short Course / Advanced Clinical Trials / Erasmus MC / Rotterdam, The Netherlands March 21-24 https://bit.ly/3s7H5rW Conference / Public Health & Wastewater Disease Surveillance Summit / Water Environment Federation / Cincinnati, OH March 23-25 https://svepm2022.org/ Conference / Annual Meeting - Society for Veterinary Epidemiology / SEVPM / Belfast, Ireland March 30 - April 1 https://bit.ly/31YqOdE Conference / 8th International Conference on Neurology & Epidemiology / International Society of Neurology & Epidemiology / VIRTUAL

DEPARTMENT OF EPIDEMIOLOGY AND PUBLIC HEALTH UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE DIVISION OF GERONTOLOGY SEARCH REOPENED

LEADERSHIP OPPORTUNITY IN AGING & PUBLIC HEALTH SCIENCES Division Director The Department of Epidemiology and Public Health of the University of Maryland School of Medicine is seeking a division director at the associate or full professor rank for an exciting opportunity to expand and accelerate the growth of the Division of Gerontology. A generous and competitive start-up package will be provided to support the division director’s research initiatives and growth of the division. The successful candidate for the division head position will be a national leader with commitment to conducting and fostering interdisciplinary research in the epidemiology of aging and gerontology, will have a record of extramural research funding, and leadership and management capabilities. The division director is expected to develop and enhance collaborative research within the division, department, and medical system, and actively teach and participate in the department’s training programs for graduate students and post-doctoral fellows. Opportunities to teach medical students and students in other professional schools on our health services campus also are possible. The division’s seven faculty members have ongoing multidisciplinary research and collaborations across campus, focused on strategies to prevent and improve outcomes from disabling conditions among older persons. Gerontology division faculty collaborate with others throughout the University of Maryland Baltimore campus, which includes six professional schools (medicine, nursing, pharmacy, dentistry, social work, and law), other University of Maryland campuses, as well as those in other academic and industry settings. The division also is the administrative home for the campus-wide Center for Research on Aging, the Claude D. Pepper Older Americans Independence Center – funded since 1994, the Gerontology Doctoral Program, and the federally funded Research Training in the Epidemiology of Aging (T32). The department, which is ranked first in NIH funding for like-departments in public schools of medicine, comprises 45 full-time faculty members, has strong research programs in cancer epidemiology, genomic and infectious disease epidemiology, translational toxicology, biostatistics, preventive medicine, and health disparities and population health. The department is also the home for doctoral degree programs in Epidemiology and Human Genetics, and in Gerontology, as well as master’s programs in epidemiology, clinical research, and public health. Qualifications: Ph.D. and/or M.D. with significant experience collaborating in an interdisciplinary research setting, background in epidemiology and/or gerontology, and an established record of extramural research funding are required. For confidential inquiries, please contact Dr. Jack Guralnik at jguralnik@som.umaryland.edu or Dr. Ann Gruber-Baldini at abaldin@som.umaryland.edu. TO APPLY: Please submit applications online at: https://umb.taleo.net/careersection/jobdetail.ftl?job=170001XK&lang=en#.WjliERVAqss.email Applications should include a cover letter indicating research interests, CV, and names of 3 references. Reference position # 03-307-143. The University of Maryland, Baltimore is an Equal Opportunity, Affirmative Action Employer. Minorities, women, veterans, and individuals with disabilities are encouraged to apply.

Open Rank Faculty – Pharmacoepidemiolgy Instructor, Assistant, Associate or Full Professor The Center for Pharmacoepidemiology and Treatment Science (PETS) at Rutgers, The State University of New Jersey invites applications for multiple faculty positions in Pharmacoepidemiology of all ranks. We are seeking exceptional researchers at all career stages (Instructor, Assistant, Associate, or Full Professor) who are dedicated to developing or maintaining their own independent research programs, have a commitment to collaborative work and graduate teaching, and show the ability to be leaders in the field of pharmacoepidemiology. Successful candidates will have an established track record of publication and funding commensurate with their career stage. Candidates from nonacademic or industry settings will have a track record of research productivity and a clear intent to pursue an independent, funded research program. PETS is committed to supporting researchers and teachers in pharmacoepidemiology who are dedicated to academic excellence and research that improves the health and wellness of individuals and populations. In addition to their appointment at PETS, applicants will receive academic appointments at Rutgers University as relevant to their background, including but not limited to the Ernest Mario School of Pharmacy, Robert Wood Johnson Medical School, New Jersey Medical School, or the School of Public Health. The majority of the faculty’s effort will be dedicated to pharmacoepidemiology research and the PETS Center. The position is full-time, tenure-track or tenured, with a competitive start-up, full support for 3 years, and the expectation of having grant support, commensurate with their career stage, by the beginning of the 4th year on the PETS faculty. The ideal candidate will have: ► A doctorate degree and doctorate-level training in pharmacoepidemiology, epidemiology, or related disciplines, or a clinical degree with Master’s level training in these fields. ► A research focus in the field of pharmacoepidemiology. ► A strong track record of peer-reviewed journal articles. ► Postdoctoral training; a K-award, R21 or R34 funding, and/or other evidence of preparation to become an R01-funded principal investigator; R01 or comparable funding (as appropriate for the candidate’s career stage).

CLICK HERE FOR ADDITIONAL INFORMATION Applicants may apply directly on our website: https://jobs.rutgers.edu/postings/150642

Tenure Track Assistant Professor The Department of Epidemiology within the Geisel School of Medicine at Dartmouth and the Norris Cotton Cancer Center (NCCC) invites applications for a tenure-track Assistant Professor position. We seek applicants to lead an independent, innovative research program in cancer epidemiology, including but not limited to: cancer prevention, etiology, early detection, survivorship, health disparities, molecular epidemiology, environmental epidemiology, or lifestyle/behavioral research. NCCC offers a dynamic and interactive environment with a commitment to research excellence. The faculty appointment will be in the Department of Epidemiology, with membership in the Cancer Population Sciences research program at NCCC. A generous start-up package, access to state-of-the-art research facilities, and excellent institutional resources are available through NCCC (one of 51 NCI-designated Comprehensive Cancer Centers). Individuals will be given opportunities for mentoring and teaching graduate students in relevant M.S. and Ph.D. programs (e.g., Quantitative Biomedical Sciences). The successful candidate may, as appropriate, also benefit from association with one of our NIH-sponsored Centers for Biomedical Research Excellence (COBRE), such as the Center for Molecular Epidemiology and the Center for Quantitative Biomedical Sciences. Training grants are available to support graduate and postdoctoral trainees, including the NCI-sponsored T32 Postdoctoral Training Program for Quantitative Biomedical Sciences in Cancer. Dartmouth College is an equal opportunity/affirmative action employer with a strong commitment to diversity and inclusion. We prohibit discrimination on the basis of race, color, religion, sex, age, national origin, sexual orientation, gender identity or expression, disability, veteran status, marital status, or any other legally protected status. Applications by members of all underrepresented groups are encouraged

Apply Here: http://apply.interfolio.com/99545

Research RFP / Aliso Canyon Disaster Health Research Study The County of Los Angeles Department of Public Health (Public Health) is pleased to announce the release of a Request for Proposals (RFP) to solicit proposals from interested qualified proposers to enter into contract with Los Angeles County to conduct the Aliso Canyon Disaster Health Research Study (Health Study). The Health Study is a study to scientifically evaluate and understand the health impacts from the largest natural gas storage facility blowout in U.S. history and exposure to natural gas and its constituents, including but not limited to methane, from the Southern California Gas Company (SoCal Gas) Aliso Canyon Natural Gas Storage Facility in Los Angeles County California. Bid Number: 2022-03 Bid Title: Aliso Canyon Disaster Health Research Study Services Release/Open Date: January 18, 2022 Closing/Due Date: April 12, 2022 by 4:00 PM Pacific Time For more information, please see: The contracting opportunity announcement linked here: https://bit.ly/34dVlFE The RFP materials listed on the Los Angeles County Department of Public Health Contracts and Grants website: https://bit.ly/3g0bq4m The Aliso Canyon Disaster Health Research Study website: https://bit.ly/32BvjeO

Advantages of a Fellowship at the NCI: Division of Cancer Epidemiology and Genetics Explore opportunities in Epidemiology, Biostatistics, Genetics Fellows are the NCI’s Division of Cancer Epidemiology and Genetics work with the world-class scientist to explore the environmental causes of cancer and new approaches to it prevention . Our research includes:

At NCI, we offer a range of predoctoral and postdoctoral fellowship with personalized mentoring, as well as specialized training partnership with several schools of public health.. As a DCEG fellow, you are supported as you take on challenges than enable you to grow both scientifically and professionally.

•Biostatics •Clinical Genetics •Genetic Epidemiology •Health Disparities •Hormonal and Reproductive Epidemiology •Infection and immunoepidemiology •Nutritional Epidemiology •Occupation and environmental epidemiology •Radiation Epidemiology •Translational Genomics

•Design, carry out, analyze, and publish population, family and laboratory-based studies •Gain experience in: •Diverse study design •Novel analytics techniques •Genomics and informatics •Build Skills in: •Molecular epidemiology •Grant writing •Professional communication and networking

Discover what NCI has to offer you – come work with some of the most committed scientist you will ever meet.

Apply Today dceg.cancer.gov

Fellowship Positions Postbaccalaureate, Predoctoral Postdoctoral Fellowship & Summer Internship

Applications accepted on an ongoing basis

Cancer Epidemiologists Multiple Tenure Track Positions Available Join the Winthrop P. Rockefeller team and help us fight the battle against cancer Multiple Research Faculty Positions Available The UAMS Winthrop P. Rockefeller Cancer Institute is seeking exceptional candidates for open rank, tenure-track Epidemiology faculty positions in the following disease site areas: breast, colorectal, lung, gynecological and prostate cancers. Underrepresented minorities and individuals with expertise in community-based research or health disparities are strongly encouraged to apply. Applicants must have an earned doctorate in Epidemiology from an accredited program and highly competent in epidemiologic methods. Priority will be given to investigators with active extramural funding. Applicants should have a strong record of recent accomplishments as a postdoctoral fellow or sustained productivity as a faculty member with high impact publications and extramural funding. Successful applicants will join one of the most prestigious cancer centers in the country. The Winthrop P. Rockefeller Cancer Institute is the only academic cancer center in the state of Arkansas with a robust cancer research portfolio treating over 2,500 new cancer patients a year and supporting nearly 270 cancer clinical trials. This recruitment is made possible through significant institutional support and a $10M annual commitment from the state of Arkansas to support the Cancer Institute’s efforts to attain NCI Designation. If you are looking for natural beauty, spectacular views and scenic waterways or prefer a thriving downtown, with a robust restaurant and music scene, complete with a low-cost-of-living, no need to choose, we can offer you both. With 52 state parks, two mountain ranges and 2,400 lakes, Arkansas is known as “the Natural State”. It ranked No. 10 on the list of Top Moving Destinations of 2020 according to United Van Lines, the nation’s largest household goods mover. Located in central Arkansas, Little Rock, the state’s capital, is centrally located in the state on the Arkansas River (http://www.littlerock.com/). Little Rock was honored in 2013 as the #1 city in Kiplinger’s 10 Great Places to Live (small to midsize city category), was also ranked in Forbes in the 15 Best Cities for Young Adults and One of Five Secret Foodie Cities, and in May 2016 was ranked as #4 in the 20 best affordable places to live in the U.S. by U.S. News and World Report (http://realestate.usnews.com/real-estate/slideshows/the-20-bestaffordable-places-to-live-in-the-us/). Applicants should send a 3-page research statement, their Curriculum Vitae, a one page letter of interest, and 3 professional references directly to Recruitment Administrator, Jennifer Moulton at jamoulton@uams.edu. Applications will be reviewed now through March 31, 2022. Selected applicants will join a diverse and vibrant academic community that values its researchers and is committed to diversity, equity and inclusion. Applicants must be able to work in a team environment. UAMS is an inclusive Affirmative Action and Equal Opportunity Employer of individuals with disabilities and protected veterans and is committed to excellence.

Epidemiology's Summer Institute at Columbia University Early discounts available until April 1, 2022 Registration open through May 1, 2022

For a Full List of Courses Offered in EPISUMMER@COLUMBIA 2022 Visit: cuepisummer.org

Your Ad Should Be Here Do you have a job, course, conference, book or other resource of interest to the epidemiology community? Advertise with The Epidemiology Monitor and reach 35,000 epidemiologists, biostatisticians, and public health professionals monthly.

Advertising opportunities exist in this digital publication, on our website and Facebook page, and in our Epi-Gram emails.

For more information please contact:

Linda Bernier, Director of Advertising / 770.533.3436 / linda@epimonitor.net

The Epidemiology Monitor in a Digital Version is available FREE to subscribers The Epidemiology Monitor is available exclusively online in the same familiar print format subscribers were accustomed to, and they can read through the publication on their electronic devices in the same manner they did with the print version. In addition, you can download and save copies of The Epidemiology Monitor for easy future access. This digital publication format provides: ► Easier access to information that is more timely ► Publication alerts via email ► Embedded hot links in articles ► Full color advertising ► Wider circulation for advertisers

SUBSCRIBE FOR FREE TODAY AT: http://epimonitor.net/Subscribe.htm